KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 163 filers reported holding KARUNA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $140,345 | -27.2% | 830 | -49.0% | 0.01% | +50.0% |
| Q2 2023 | $192,804 | +1064.8% | 1,628 | +96.9% | 0.00% | +300.0% |
| Q1 2023 | $16,552 | +45877.8% | 827 | +55.5% | 0.00% | 0.0% |
| Q4 2022 | $36 | -99.9% | 532 | +42.2% | 0.00% | 0.0% |
| Q3 2022 | $35,000 | – | 374 | – | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q1 2021 | $127,000 | +32.3% | 1,039 | +10.5% | 0.00% | -50.0% |
| Q4 2020 | $96,000 | +37.1% | 940 | +1.5% | 0.00% | 0.0% |
| Q3 2020 | $70,000 | – | 926 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $142,043,933 | 58.49% |
| Nan Fung Group Holdings Ltd | 225,688 | $40,993,968 | 27.90% |
| Sofinnova Investments, Inc. | 1,773,124 | $322,070,243 | 20.60% |
| Artia Global Partners LP | 88,831 | $16,135,263 | 5.96% |
| DAFNA Capital Management LLC | 78,573 | $14,272,000 | 4.28% |
| First Light Asset Management, LLC | 243,675 | $44,261,127 | 3.98% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $3,966,473 | 2.74% |
| Sands Capital Ventures, LLC | 58,895 | $10,697,688 | 2.64% |
| ARCH Venture Management, LLC | 30,000 | $5,449,200 | 2.63% |
| Logos Global Management LP | 100,000 | $18,164,000 | 2.60% |